´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ¼¿ï °Å¹®°íȦ
±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : Ãֹ̼Ò
¿¬¶ôó : 02-6395-2876
À̸ÞÀÏ : movement@kmds.or.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í »çÀüµî·Ï : 80,000¿ø / ÁØȸ¿ø 50,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 160,000¿ø / ºñȸ¿ø Àü°øÀÇ 60,000¿ø ÇöÀåµî·Ï : Çмú´ëȸ : Á¤È¸¿ø 100,000¿ø / ÁØȸ¿ø 60,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 200,000¿ø / ºñȸ¿ø Àü°øÀÇ 70,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 09:00~09:35 Treatment Based on Semiology or on Genetics or Both? : Focus on Dystonia Marie Vidailhet(Hôpital de la Pitié-Salpêtrière Paris France)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 09:35~10:10 Surgical Treatment for Movement Disorders Alfonso Fasano(University of Toronto Canada)
Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 10:10~10:15 Q&A ¹éÁ¾»ï(ÀÎÁ¦ÀÇ´ë)
ÈÞ½Ä 04¿ù 29ÀÏ 10:15~10:25 ÈÞ½Ä ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 10:25~10:55 Mechanism and Application of Immunologic Treatment for Movement Disorders À̼øÅÂ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 10:55~11:25 Updates in Rehabilitation for Parkinson Àå¿øÇõ(¼º±Õ°üÀÇ´ë ÀçÈ°ÀÇÇаú)
Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 11:25~11:30 Q&A Á¶Áøȯ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 11:30~12:10 Genetic Landscape of Parkinson''s Disease ±èÀ±Áß(¿¬¼¼ÀÇ´ë)
½Ä»ç 04¿ù 29ÀÏ 12:10~13:05 ½Ä»ç ( )
Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 13:05~14:00 Poster Session : Guided Poster Tour ±è¿µÀº ¿ÀÀÀ¼® Àå¿ì¿µ(ÇѸ²ÀÇ´ë Ãæ³²ÀÇ´ë ¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 14:00~14:30 Nigrosome 1, Neuromelanin, and Novel Imaging Analysis for Movement Disorders ±èÀÀ¿±(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 14:30~15:00 Digital Biomarker for Movement Disorders ¹ÚÁø¼¼(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 15:00~15:30 Imaging and Laboratory Tests in the Diagnosis of MSA and DLB À¯ÇѼö(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 04¿ù 29ÀÏ 15:30~15:40 ÈÞ½Ä ( )
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 15:40~16:00 Drug Repurposing in Movement Disorder À̸íÁØ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 16:00~16:20 Pathologic Alpha-synuclein Protein Targeting Antibody Immunotherapy ¾È¼º¿ø(ABL Bio)
±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼¿ïÈ£ÅÚ °Å¹®°íȦ 16:20~16:40 CBD Oil and Glutathione for PD: Do they Work? À±Áö¿µ(ÀÌÈÀÇ´ë)